Phase II Study of Single-Agent Navitoclax (ABT-263) and Biomarker Correlates in Patients with Relapsed Small Cell Lung Cancer
Clinical cancer research, 2012-06, Vol.18 (11), p.3163-3169 [Peer Reviewed Journal]2015 INIST-CNRS ;2012 AACR. 2012 ;ISSN: 1078-0432 ;EISSN: 1557-3265 ;DOI: 10.1158/1078-0432.CCR-11-3090 ;PMID: 22496272 ;CODEN: CCREF4
Full text available